These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6242101)

  • 1. [Use of homologous vaccine in Pseudomonas aeruginosa infection of the urinary tract in rats].
    Sprogis J
    Ann Acad Med Stetin; 1984; 30():371-84. PubMed ID: 6242101
    [No Abstract]   [Full Text] [Related]  

  • 2. New possibility for providing protection against urinary tract infection caused by Pseudomonas aeruginosa by non-adjuvanted flagellin 'b' induced immunity.
    Sabharwal N; Chhibber S; Harjai K
    Immunol Lett; 2014 Dec; 162(2 Pt B):229-38. PubMed ID: 25455605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
    Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
    Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections.
    Mittal R; Sharma S; Chhibber S; Harjai K
    J Biomed Sci; 2008 Nov; 15(6):731-41. PubMed ID: 18688758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community-acquired Pseudomonas aeruginosa urinary tract infection in young children.
    Mocan H; Karagüzel G
    Pediatr Nephrol; 1997 Dec; 11(6):784-5. PubMed ID: 9438666
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunomodulation in Pseudomonas urinary infection].
    Urban M; Tamele L
    Rozhl Chir; 1995 Nov; 74(7):319-21. PubMed ID: 8629153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of the renal pelvis to infection: a scanning electron microscopic study.
    Cohen MS; Davis CP; Warren MM
    Invest Urol; 1979 Mar; 16(5):360-4. PubMed ID: 429132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced immune response in "R" inbred rats by chemical and/or bacterial immunostimulation. I. Protection induced by Aerodin and Bronhodin associated or not with levamisole against experimental infection with Pseudomonas aeruginosa or grafting HR18 tumoral cells.
    Popescu C; Pencea I; Hoişie S; Economu D; Anton D; Grecu V; Scorţea D; Pop I
    Arch Roum Pathol Exp Microbiol; 1985; 44(1):43-53. PubMed ID: 3929748
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigations on the efficacy of specific immunization with corpuscular vaccines in urinary tract infections with Pseudomonas aeruginosa or mixed bacteria.
    Neagu V; Meitert E; Ioanid CP; Racovită C; Găleşanu M; Sima F; Savulian C; Momiceanu D; Noica N; Neagoe M
    Arch Roum Pathol Exp Microbiol; 1984; 43(1):39-52. PubMed ID: 6442131
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.
    Cachia PJ; Hodges RS
    Biopolymers; 2003; 71(2):141-68. PubMed ID: 12767116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W
    Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310
    [No Abstract]   [Full Text] [Related]  

  • 12. A new polyvalent pseudomonas vaccine.
    Merle P; Robbel L; Hungerer KD
    Behring Inst Mitt; 1984 Nov; (76):113-20. PubMed ID: 6441560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mono--and polyvalent Pseudomonas aeruginosa vaccines. Preparation, control and administration.
    Meitert E; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):105-14. PubMed ID: 6816188
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial.
    Hopkins WJ; Elkahwaji J; Beierle LM; Leverson GE; Uehling DT
    J Urol; 2007 Apr; 177(4):1349-53; quiz 1591. PubMed ID: 17382730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
    Gerasimova LI; Moroz AF; Radkevich SA; Sveshnikov AI; Mizikin EV
    Khirurgiia (Mosk); 1980 Nov; (11):36-41. PubMed ID: 6777578
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).
    Joó I; Stanislavskii ES
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.